The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...

A Pfizer Inc. PFE, -0.48% vaccine designed to protect babies from respiratory syncytial virus, or RSV, got a green light Monday from the U.S. Food and Drug Administration — a key milestone for ...

An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...

The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's ...

(The Hill) – The Food and Drug Administration (FDA) on Monday approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to pregnant mothers ...

One month after the FDA’s initial approval, the CDC voted to recommend Pfizer’s RSV vaccine for pregnant people who are ...

Fall vaccination season is in full swing, with health officials urging both an updated COVID-19 shot and flu vaccine for most ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. RSV is a disease that’s common in children.

Now, for the first time, a vaccine is approved for adults 60 and older. But what is RSV? RSV stands for respiratory syncytial ...

Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...

US FDA Approves Pfizer's Maternal RSV Vaccine to Protect Infants By Patrick Wingrove and Bhanvi Satija (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory ...

The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...